Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity

Hormone and Metabolic Research

Volumn 28, Issue 12, 1996, Pages 737-743

  Kellerer, M ^a   Rett, K ^a   Renn, W ^a   Groop, L ^b   Haring H U ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

insulin resistance; leptin; NIDDM; obesity; tumor necrosis factor

Indexed keywords

LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROGENY; REGRESSION ANALYSIS; SKELETAL MUSCLE;

EID: 0030481074     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979890     Document Type: Article

References (27)

1. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15: 318-368 (1992).
2. Beck-Nielsen H, Groop LC: Metabolic and genetic characterization of prediabetic states. J Clin Invest 94: 1714-1721 (1994).
3. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337-343 (1989).
4. Beck-Nielsen H, Hother-Nielsen O, Vaag A, Alford F: Pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycemia. A critical comment. Diabetologia 37: 217-221 (1994).
5. Bjorntorp P: Metabolic implication of body fat distribution. Diabetes Care 14: 1132-1143 (1991).
6. Freidenberg GR, Reichart D, Olefsky JM, Henry RR: Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. J Clin Invest 82: 1398-1406 (1988).
7. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 84: 205-213 (1989).
8. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-de-pendent diabetes mellitus. J Clin Endocrinol Metab 72: 96-107 (1991).
9. Hotamisligil GS, Sjargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91 (1993).
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415 (1995).
11. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM: Reduced tyrosine kinase ctivity of the insulin receptor in obesity-diabetes. J Clin Invest 94: 1543-1549 (1994).
12. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-431 (1994).
13. Schwartz MW, Bakin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531-535 (1996).
14. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495 (1996).
15. Zang B, Graziano MP, Doebber TW, Leibowitz MD, White-Carrington S, Szalkowski DM, Hey PJ, Wu M, Cullinan CA, Bailey P, Lollmann B, Frederich R, Flier JS, Strader CD, Smith RG: Down regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271: 9455-9459 (1996).
16. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A: Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058 (1993).
17. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 271: 665-668 (1996).
18. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A, Berti L, Horikoshi H, Ullrich A, Häring HU: Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signalling. J Clin Invest 97: 1471-1477 (1996).
19. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1: 1155-1160 (1995).
20. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, Snodgrass HR: Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. Nature Med 2: 585-589 (1996).
21. Kroder G, Kellerer M, Häring HU: Effect of leptin on insulin signalling in rat-1 fibroblasts overexpressing HIR. Exp Clin Endocrinol Diab 104 (Suppl 2): 66 (1996).
22. Forsblom CM, Eriksson JG, Ekstrand AV, Teppo A-M, Taskinen M-R, Groop LC: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Dibetologia 38: 363-369 (1995).
23. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057 (1979).
24. Bienvenu J, Coulon L, Doche ÖC, Gutowski MC, Grau GE: Analytical performances of commercial ELISA-kits for IL-2, IL-6 and TNFα. A WHO study. Eur Cytokine Netw 4: 447-451 (1993).
25. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. NEJM 334: 292-295 (1996).
26. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNF-alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97: 1111-1116 (1996).
27. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45: 881-885 (1996).